n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, VV; Deppe, G; Diamond, MP; Genhai, Z; Morris, R; Munkarah, AR; Saed, GM | 1 |
| Chen, Y; Gu, KS | 1 |
| Kim, HS; Lee, BM; Lim, JS; Park, Y; Yoon, S | 1 |
3 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and paclitaxel
| Article | Year |
|---|---|
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Female; Flow Cytometry; Humans; Isoenzymes; Membrane Proteins; Nitrobenzenes; Ovarian Neoplasms; Paclitaxel; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Tumor Cells, Cultured | 2003 |
Mechanism of P-glycoprotein expression in the SGC7901 human gastric adenocarcinoma cell line induced by cyclooxygenase-2.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; NF-kappa B; Nitrobenzenes; Paclitaxel; Proline; Signal Transduction; Stomach Neoplasms; Sulfonamides; Thiocarbamates; Tumor Cells, Cultured | 2012 |
Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimitotic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Drug Resistance, Neoplasm; Drug Synergism; Humans; Nitrobenzenes; Paclitaxel; Sulfonamides; Vinblastine | 2016 |